Research, innovation and market-trend explainers — the context behind the headlines, written for people who work in the industry.
ResearchA clear overview of GVP Module VI, explaining ICSR requirements, timelines, and EudraVigilance reporting in the EU.
ResearchHow Good Pharmacovigilance Practices are evolving from compliance into a strategic growth and trust-building function in pharma.
ResearchA strategic look at non-viral drug delivery systems, their advantages, limitations, and growing role in RNA, gene, and precision therapies.
Market TrendsA deep dive into the biggest pharma mergers of 2025 and how targeted acquisitions reshaped pipelines, innovation strategy, and long-term growth.
ResearchAI vision systems are reshaping pharma quality control by detecting contamination faster, improving consistency, and strengthening compliance.
InnovationNext-gen CAR-T cells are designed to overcome the tumor microenvironment and finally make solid tumor immunotherapy possible.
ResearchZosurabalpin is a first-in-class antibiotic targeting Gram-negative superbugs and offering new hope against antimicrobial resistance.
ResearchAlzheimer’s drug pipelines are evolving as amyloid antibodies, oral agents, and precision trials redefine disease-modifying strategies.
InnovationNon-viral delivery systems enable safer, scalable gene therapy and mRNA delivery, reshaping advanced therapeutics beyond viral vectors.
InnovationRaman spectroscopy and hyperspectral imaging enable faster, non-destructive pharmaceutical QC with deep chemical insight and spatial accuracy.
ResearchExplore how CCS strengthens sterility, reduces deviations, and drives proactive contamination control in pharma.
ResearchFlow chemistry and smart delivery systems are redefining drug design, precision dosing, and personalized medicine.